世界のTCR療法市場規模・現状・予測2021-2027

【英語タイトル】Global TCR Therapy Market Size, Status and Forecast 2021-2027

QYResearchが出版した調査資料(QY21JNE2941)・商品コード:QY21JNE2941
・発行会社(調査会社):QYResearch
・発行日:2021年6月
・ページ数:109
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥510,900見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥766,350見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査資料では、TCR療法の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(キメラ抗原受容体シグナル伝達、TCRα/βヘテロダイマーシグナル伝達)、用途別市場規模(病院、診療所・外来センター、がん研究所、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・TCR療法の市場動向
・企業の競争状況、市場シェア
・TCR療法の種類別市場規模(キメラ抗原受容体シグナル伝達、TCRα/βヘテロダイマーシグナル伝達)
・TCR療法の用途別市場規模(病院、診療所・外来センター、がん研究所、その他)
・TCR療法の北米市場規模2016-2027(アメリカ、カナダ)
・TCR療法の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・TCR療法のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・TCR療法の中南米市場規模2016-2027(メキシコ、ブラジル)
・TCR療法の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Adaptimmune Therapeutics PLC、Immunocore、Medigene、Adaptive Biotechnologies、Lion TCR、TCR2 Therapeutics, Inc.、RootPath、Kite Pharma、Guangzhou Xiangxue Pharmaceutical Co., Ltd、Eureka Therapeutics)
・結論
【レポートの概要】

Market Analysis and Insights: Global TCR Therapy Market
The global TCR Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global TCR Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global TCR Therapy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global TCR Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global TCR Therapy market.

Global TCR Therapy Scope and Market Size
TCR Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global TCR Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Transduction of Chimeric Antigen Receptor
Transduction of TCR α/β Heterodimer

Segment by Application
Hospitals
Clinics & Ambulatory Centers
Cancer Research Institutes
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Adaptimmune Therapeutics PLC
Immunocore
Medigene
Adaptive Biotechnologies
Lion TCR
TCR2 Therapeutics, Inc.
RootPath
Kite Pharma
Guangzhou Xiangxue Pharmaceutical Co., Ltd
Eureka Therapeutics

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global TCR Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Transduction of Chimeric Antigen Receptor
1.2.3 Transduction of TCR α/β Heterodimer
1.3 Market by Application
1.3.1 Global TCR Therapy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics & Ambulatory Centers
1.3.4 Cancer Research Institutes
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global TCR Therapy Market Perspective (2016-2027)
2.2 TCR Therapy Growth Trends by Regions
2.2.1 TCR Therapy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 TCR Therapy Historic Market Share by Regions (2016-2021)
2.2.3 TCR Therapy Forecasted Market Size by Regions (2022-2027)
2.3 TCR Therapy Industry Dynamic
2.3.1 TCR Therapy Market Trends
2.3.2 TCR Therapy Market Drivers
2.3.3 TCR Therapy Market Challenges
2.3.4 TCR Therapy Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top TCR Therapy Players by Revenue
3.1.1 Global Top TCR Therapy Players by Revenue (2016-2021)
3.1.2 Global TCR Therapy Revenue Market Share by Players (2016-2021)
3.2 Global TCR Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by TCR Therapy Revenue
3.4 Global TCR Therapy Market Concentration Ratio
3.4.1 Global TCR Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by TCR Therapy Revenue in 2020
3.5 TCR Therapy Key Players Head office and Area Served
3.6 Key Players TCR Therapy Product Solution and Service
3.7 Date of Enter into TCR Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans

4 TCR Therapy Breakdown Data by Type
4.1 Global TCR Therapy Historic Market Size by Type (2016-2021)
4.2 Global TCR Therapy Forecasted Market Size by Type (2022-2027)

5 TCR Therapy Breakdown Data by Application
5.1 Global TCR Therapy Historic Market Size by Application (2016-2021)
5.2 Global TCR Therapy Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America TCR Therapy Market Size (2016-2027)
6.2 North America TCR Therapy Market Size by Type
6.2.1 North America TCR Therapy Market Size by Type (2016-2021)
6.2.2 North America TCR Therapy Market Size by Type (2022-2027)
6.2.3 North America TCR Therapy Market Size by Type (2016-2027)
6.3 North America TCR Therapy Market Size by Application
6.3.1 North America TCR Therapy Market Size by Application (2016-2021)
6.3.2 North America TCR Therapy Market Size by Application (2022-2027)
6.3.3 North America TCR Therapy Market Size by Application (2016-2027)
6.4 North America TCR Therapy Market Size by Country
6.4.1 North America TCR Therapy Market Size by Country (2016-2021)
6.4.2 North America TCR Therapy Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe TCR Therapy Market Size (2016-2027)
7.2 Europe TCR Therapy Market Size by Type
7.2.1 Europe TCR Therapy Market Size by Type (2016-2021)
7.2.2 Europe TCR Therapy Market Size by Type (2022-2027)
7.2.3 Europe TCR Therapy Market Size by Type (2016-2027)
7.3 Europe TCR Therapy Market Size by Application
7.3.1 Europe TCR Therapy Market Size by Application (2016-2021)
7.3.2 Europe TCR Therapy Market Size by Application (2022-2027)
7.3.3 Europe TCR Therapy Market Size by Application (2016-2027)
7.4 Europe TCR Therapy Market Size by Country
7.4.1 Europe TCR Therapy Market Size by Country (2016-2021)
7.4.2 Europe TCR Therapy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific TCR Therapy Market Size (2016-2027)
8.2 Asia-Pacific TCR Therapy Market Size by Type
8.2.1 Asia-Pacific TCR Therapy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific TCR Therapy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific TCR Therapy Market Size by Type (2016-2027)
8.3 Asia-Pacific TCR Therapy Market Size by Application
8.3.1 Asia-Pacific TCR Therapy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific TCR Therapy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific TCR Therapy Market Size by Application (2016-2027)
8.4 Asia-Pacific TCR Therapy Market Size by Region
8.4.1 Asia-Pacific TCR Therapy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific TCR Therapy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America TCR Therapy Market Size (2016-2027)
9.2 Latin America TCR Therapy Market Size by Type
9.2.1 Latin America TCR Therapy Market Size by Type (2016-2021)
9.2.2 Latin America TCR Therapy Market Size by Type (2022-2027)
9.2.3 Latin America TCR Therapy Market Size by Type (2016-2027)
9.3 Latin America TCR Therapy Market Size by Application
9.3.1 Latin America TCR Therapy Market Size by Application (2016-2021)
9.3.2 Latin America TCR Therapy Market Size by Application (2022-2027)
9.3.3 Latin America TCR Therapy Market Size by Application (2016-2027)
9.4 Latin America TCR Therapy Market Size by Country
9.4.1 Latin America TCR Therapy Market Size by Country (2016-2021)
9.4.2 Latin America TCR Therapy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa TCR Therapy Market Size (2016-2027)
10.2 Middle East & Africa TCR Therapy Market Size by Type
10.2.1 Middle East & Africa TCR Therapy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa TCR Therapy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa TCR Therapy Market Size by Type (2016-2027)
10.3 Middle East & Africa TCR Therapy Market Size by Application
10.3.1 Middle East & Africa TCR Therapy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa TCR Therapy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa TCR Therapy Market Size by Application (2016-2027)
10.4 Middle East & Africa TCR Therapy Market Size by Country
10.4.1 Middle East & Africa TCR Therapy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa TCR Therapy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Adaptimmune Therapeutics PLC
11.1.1 Adaptimmune Therapeutics PLC Company Details
11.1.2 Adaptimmune Therapeutics PLC Business Overview
11.1.3 Adaptimmune Therapeutics PLC TCR Therapy Introduction
11.1.4 Adaptimmune Therapeutics PLC Revenue in TCR Therapy Business (2016-2021)
11.1.5 Adaptimmune Therapeutics PLC Recent Development
11.2 Immunocore
11.2.1 Immunocore Company Details
11.2.2 Immunocore Business Overview
11.2.3 Immunocore TCR Therapy Introduction
11.2.4 Immunocore Revenue in TCR Therapy Business (2016-2021)
11.2.5 Immunocore Recent Development
11.3 Medigene
11.3.1 Medigene Company Details
11.3.2 Medigene Business Overview
11.3.3 Medigene TCR Therapy Introduction
11.3.4 Medigene Revenue in TCR Therapy Business (2016-2021)
11.3.5 Medigene Recent Development
11.4 Adaptive Biotechnologies
11.4.1 Adaptive Biotechnologies Company Details
11.4.2 Adaptive Biotechnologies Business Overview
11.4.3 Adaptive Biotechnologies TCR Therapy Introduction
11.4.4 Adaptive Biotechnologies Revenue in TCR Therapy Business (2016-2021)
11.4.5 Adaptive Biotechnologies Recent Development
11.5 Lion TCR
11.5.1 Lion TCR Company Details
11.5.2 Lion TCR Business Overview
11.5.3 Lion TCR TCR Therapy Introduction
11.5.4 Lion TCR Revenue in TCR Therapy Business (2016-2021)
11.5.5 Lion TCR Recent Development
11.6 TCR2 Therapeutics, Inc.
11.6.1 TCR2 Therapeutics, Inc. Company Details
11.6.2 TCR2 Therapeutics, Inc. Business Overview
11.6.3 TCR2 Therapeutics, Inc. TCR Therapy Introduction
11.6.4 TCR2 Therapeutics, Inc. Revenue in TCR Therapy Business (2016-2021)
11.6.5 TCR2 Therapeutics, Inc. Recent Development
11.7 RootPath
11.7.1 RootPath Company Details
11.7.2 RootPath Business Overview
11.7.3 RootPath TCR Therapy Introduction
11.7.4 RootPath Revenue in TCR Therapy Business (2016-2021)
11.7.5 RootPath Recent Development
11.8 Kite Pharma
11.8.1 Kite Pharma Company Details
11.8.2 Kite Pharma Business Overview
11.8.3 Kite Pharma TCR Therapy Introduction
11.8.4 Kite Pharma Revenue in TCR Therapy Business (2016-2021)
11.8.5 Kite Pharma Recent Development
11.9 Guangzhou Xiangxue Pharmaceutical Co., Ltd
11.9.1 Guangzhou Xiangxue Pharmaceutical Co., Ltd Company Details
11.9.2 Guangzhou Xiangxue Pharmaceutical Co., Ltd Business Overview
11.9.3 Guangzhou Xiangxue Pharmaceutical Co., Ltd TCR Therapy Introduction
11.9.4 Guangzhou Xiangxue Pharmaceutical Co., Ltd Revenue in TCR Therapy Business (2016-2021)
11.9.5 Guangzhou Xiangxue Pharmaceutical Co., Ltd Recent Development
11.10 Eureka Therapeutics
11.10.1 Eureka Therapeutics Company Details
11.10.2 Eureka Therapeutics Business Overview
11.10.3 Eureka Therapeutics TCR Therapy Introduction
11.10.4 Eureka Therapeutics Revenue in TCR Therapy Business (2016-2021)
11.10.5 Eureka Therapeutics Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global TCR Therapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Transduction of Chimeric Antigen Receptor
Table 3. Key Players of Transduction of TCR α/β Heterodimer
Table 4. Global TCR Therapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global TCR Therapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global TCR Therapy Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global TCR Therapy Market Share by Regions (2016-2021)
Table 8. Global TCR Therapy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global TCR Therapy Market Share by Regions (2022-2027)
Table 10. TCR Therapy Market Trends
Table 11. TCR Therapy Market Drivers
Table 12. TCR Therapy Market Challenges
Table 13. TCR Therapy Market Restraints
Table 14. Global TCR Therapy Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global TCR Therapy Market Share by Players (2016-2021)
Table 16. Global Top TCR Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in TCR Therapy as of 2020)
Table 17. Ranking of Global Top TCR Therapy Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by TCR Therapy Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players TCR Therapy Product Solution and Service
Table 21. Date of Enter into TCR Therapy Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global TCR Therapy Market Size by Type (2016-2021) (US$ Million)
Table 24. Global TCR Therapy Revenue Market Share by Type (2016-2021)
Table 25. Global TCR Therapy Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global TCR Therapy Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global TCR Therapy Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global TCR Therapy Revenue Market Share by Application (2016-2021)
Table 29. Global TCR Therapy Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global TCR Therapy Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America TCR Therapy Market Size by Type (2016-2021) (US$ Million)
Table 32. North America TCR Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America TCR Therapy Market Size by Application (2016-2021) (US$ Million)
Table 34. North America TCR Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America TCR Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America TCR Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe TCR Therapy Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe TCR Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe TCR Therapy Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe TCR Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe TCR Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe TCR Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific TCR Therapy Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific TCR Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific TCR Therapy Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific TCR Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific TCR Therapy Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific TCR Therapy Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America TCR Therapy Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America TCR Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America TCR Therapy Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America TCR Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America TCR Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America TCR Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa TCR Therapy Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa TCR Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa TCR Therapy Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa TCR Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa TCR Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa TCR Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 61. Adaptimmune Therapeutics PLC Company Details
Table 62. Adaptimmune Therapeutics PLC Business Overview
Table 63. Adaptimmune Therapeutics PLC TCR Therapy Product
Table 64. Adaptimmune Therapeutics PLC Revenue in TCR Therapy Business (2016-2021) & (US$ Million)
Table 65. Adaptimmune Therapeutics PLC Recent Development
Table 66. Immunocore Company Details
Table 67. Immunocore Business Overview
Table 68. Immunocore TCR Therapy Product
Table 69. Immunocore Revenue in TCR Therapy Business (2016-2021) & (US$ Million)
Table 70. Immunocore Recent Development
Table 71. Medigene Company Details
Table 72. Medigene Business Overview
Table 73. Medigene TCR Therapy Product
Table 74. Medigene Revenue in TCR Therapy Business (2016-2021) & (US$ Million)
Table 75. Medigene Recent Development
Table 76. Adaptive Biotechnologies Company Details
Table 77. Adaptive Biotechnologies Business Overview
Table 78. Adaptive Biotechnologies TCR Therapy Product
Table 79. Adaptive Biotechnologies Revenue in TCR Therapy Business (2016-2021) & (US$ Million)
Table 80. Adaptive Biotechnologies Recent Development
Table 81. Lion TCR Company Details
Table 82. Lion TCR Business Overview
Table 83. Lion TCR TCR Therapy Product
Table 84. Lion TCR Revenue in TCR Therapy Business (2016-2021) & (US$ Million)
Table 85. Lion TCR Recent Development
Table 86. TCR2 Therapeutics, Inc. Company Details
Table 87. TCR2 Therapeutics, Inc. Business Overview
Table 88. TCR2 Therapeutics, Inc. TCR Therapy Product
Table 89. TCR2 Therapeutics, Inc. Revenue in TCR Therapy Business (2016-2021) & (US$ Million)
Table 90. TCR2 Therapeutics, Inc. Recent Development
Table 91. RootPath Company Details
Table 92. RootPath Business Overview
Table 93. RootPath TCR Therapy Product
Table 94. RootPath Revenue in TCR Therapy Business (2016-2021) & (US$ Million)
Table 95. RootPath Recent Development
Table 96. Kite Pharma Company Details
Table 97. Kite Pharma Business Overview
Table 98. Kite Pharma Revenue in TCR Therapy Business (2016-2021) & (US$ Million)
Table 99. Kite Pharma Recent Development
Table 100. Guangzhou Xiangxue Pharmaceutical Co., Ltd Company Details
Table 101. Guangzhou Xiangxue Pharmaceutical Co., Ltd Business Overview
Table 102. Guangzhou Xiangxue Pharmaceutical Co., Ltd TCR Therapy Product
Table 103. Guangzhou Xiangxue Pharmaceutical Co., Ltd Revenue in TCR Therapy Business (2016-2021) & (US$ Million)
Table 104. Guangzhou Xiangxue Pharmaceutical Co., Ltd Recent Development
Table 105. Eureka Therapeutics Company Details
Table 106. Eureka Therapeutics Business Overview
Table 107. Eureka Therapeutics TCR Therapy Product
Table 108. Eureka Therapeutics Revenue in TCR Therapy Business (2016-2021) & (US$ Million)
Table 109. Eureka Therapeutics Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global TCR Therapy Market Share by Type: 2020 VS 2027
Figure 2. Transduction of Chimeric Antigen Receptor Features
Figure 3. Transduction of TCR α/β Heterodimer Features
Figure 4. Global TCR Therapy Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Clinics & Ambulatory Centers Case Studies
Figure 7. Cancer Research Institutes Case Studies
Figure 8. Others Case Studies
Figure 9. TCR Therapy Report Years Considered
Figure 10. Global TCR Therapy Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global TCR Therapy Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global TCR Therapy Market Share by Regions: 2020 VS 2027
Figure 13. Global TCR Therapy Market Share by Regions (2022-2027)
Figure 14. Global TCR Therapy Market Share by Players in 2020
Figure 15. Global Top TCR Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in TCR Therapy as of 2020
Figure 16. The Top 10 and 5 Players Market Share by TCR Therapy Revenue in 2020
Figure 17. Global TCR Therapy Revenue Market Share by Type (2016-2021)
Figure 18. Global TCR Therapy Revenue Market Share by Type (2022-2027)
Figure 19. North America TCR Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America TCR Therapy Market Share by Type (2016-2027)
Figure 21. North America TCR Therapy Market Share by Application (2016-2027)
Figure 22. North America TCR Therapy Market Share by Country (2016-2027)
Figure 23. United States TCR Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada TCR Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe TCR Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe TCR Therapy Market Share by Type (2016-2027)
Figure 27. Europe TCR Therapy Market Share by Application (2016-2027)
Figure 28. Europe TCR Therapy Market Share by Country (2016-2027)
Figure 29. Germany TCR Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France TCR Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. TCR Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy TCR Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia TCR Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic TCR Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific TCR Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific TCR Therapy Market Share by Type (2016-2027)
Figure 37. Asia-Pacific TCR Therapy Market Share by Application (2016-2027)
Figure 38. Asia-Pacific TCR Therapy Market Share by Region (2016-2027)
Figure 39. China TCR Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan TCR Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea TCR Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia TCR Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India TCR Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia TCR Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America TCR Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America TCR Therapy Market Share by Type (2016-2027)
Figure 47. Latin America TCR Therapy Market Share by Application (2016-2027)
Figure 48. Latin America TCR Therapy Market Share by Country (2016-2027)
Figure 49. Mexico TCR Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil TCR Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa TCR Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa TCR Therapy Market Share by Type (2016-2027)
Figure 53. Middle East & Africa TCR Therapy Market Share by Application (2016-2027)
Figure 54. Middle East & Africa TCR Therapy Market Share by Country (2016-2027)
Figure 55. Turkey TCR Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia TCR Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE TCR Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Adaptimmune Therapeutics PLC Revenue Growth Rate in TCR Therapy Business (2016-2021)
Figure 59. Immunocore Revenue Growth Rate in TCR Therapy Business (2016-2021)
Figure 60. Medigene Revenue Growth Rate in TCR Therapy Business (2016-2021)
Figure 61. Adaptive Biotechnologies Revenue Growth Rate in TCR Therapy Business (2016-2021)
Figure 62. Lion TCR Revenue Growth Rate in TCR Therapy Business (2016-2021)
Figure 63. TCR2 Therapeutics, Inc. Revenue Growth Rate in TCR Therapy Business (2016-2021)
Figure 64. RootPath Revenue Growth Rate in TCR Therapy Business (2016-2021)
Figure 65. Kite Pharma Revenue Growth Rate in TCR Therapy Business (2016-2021)
Figure 66. Guangzhou Xiangxue Pharmaceutical Co., Ltd Revenue Growth Rate in TCR Therapy Business (2016-2021)
Figure 67. Eureka Therapeutics Revenue Growth Rate in TCR Therapy Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed


★調査レポート[世界のTCR療法市場規模・現状・予測2021-2027] (コード:QY21JNE2941)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のTCR療法市場規模・現状・予測2021-2027]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆